Jayson Rieger - Nov 5, 2024 Form 3 Insider Report for Verrica Pharmaceuticals Inc. (VRCA)

Role
CEO and President, Director
Signature
/s/ Christopher Hayes, Attorney-in-Fact
Stock symbol
VRCA
Transactions as of
Nov 5, 2024
Transactions value $
$0
Form type
3
Date filed
11/6/2024, 08:59 PM
Next filing
Nov 6, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding VRCA Common Stock 552K Nov 5, 2024 Direct
holding VRCA Common Stock 150 Nov 5, 2024 By child
holding VRCA Common Stock 2.3K Nov 5, 2024 By trust F1
holding VRCA Common Stock 2.3K Nov 5, 2024 By trust F1
holding VRCA Common Stock 2.3K Nov 5, 2024 By trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are held in separate trusts for the benefit of the Reporting Person's immediate family members. The Reporting Person is a co-trustee of each trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.